Levrett Plc Big data in biotech

Alphabet Inc (NASDAC:GOOGL) executive chairman Eric Schmidt on Monday pointed out six game changing technologies, or what he calls moonshots, that he thinks will improve important parts of society. This was highlighted on the fortune.com website. One interesting idea that caught my eye was the use of mobile phones and medical data. I wrote about this several months ago in an article about the IoT (Internet of things), where the increasing use of wearable technology would become an everyday occurrence. Devices monitoring your health could transmit important data to doctors or hospitals along with your GPS position if needed. This use of big data in biotech was just one of the ideas Eric Shcmidt talked about.

DirectorsTalk asked Pascal Hughes the CEO of Levrett Plc for his thoughts: “The intersection of medicine and big data and its potential impact across the whole spectrum of healthcare from changing clinical trials to improved patient outcomes and personalised medicine is one we are only at the very beginning of understanding. For founders and investors who correctly identify how best to harness the two the rewards will be enormous. Eric Smidt of Google/Alphabet identified it as one of the six most important tech trends that will shape the future speaking at the Milken Institute Conference in Los Angeles this week.”

Levrett Plc (LON:LVRT) are currently in the process of identifying an acquisition focused in the Pharmaceutical and Biotechnology sector. Following completion of an acquisition, the objective will be to operate the acquired business and implement an operating strategy with a view to generating value for its shareholders through operational and product development as well as possible complimentary acquisitions. The Levrett Board has significant expertise in:

Working in the Biotechnology sector
Recognising and commercialising key developments in the sector
Financing and developing businesses
Investing in early stage opportunities

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Levrett Plc

    More articles like this

    Levrett Plc

    Levrett Plc Final Results and Annual Report

    Levrett PLC (LON:LVRT), a Company formed to acquire a target company with realisable or developed commercial technologies in the pharmaceutical and biotechnology sector, today announced its final results for the period ended 31 March 2017 and

    Levrett Plc

    Levrett Plc Biotech: Bull market or Bubble?

    Levrett Plc (LON:LVRT), a Company formed to acquire a target company with realisable or developed commercial technologies in the pharmaceutical and biotechnology sector, today made the following comment regarding the Timmerman Report which was published earlier

    Levrett Plc

    Levrett Plc comments on an unprecedented cancer research effort

    Levrett Plc (LON:LVRT) CEO Pascal Hughes, said: “Sean Parker of Napster and Facebook fame joins a list of tech based philanthropists starting initiatives in the Biotech and Lifescience sector with this collaborative initiative in immuno-oncology which

    Levrett Plc

    Levrett Plc Strategy, Biotechnology, Success and Focus

    Levrett Plc (LON:LVRT) Chief Executive Officer Pascal Hughes caught up with DirectorsTalk to chat about strategy, the biotech sector, the future for this sector and due diligence. Levrett Plc, a Company formed to acquire a target